Variant Update on ASCC1 : Characterization of the First Homozygous Missense Variant Involved in Prenatal‐Onset Spinal Muscular Atrophy With Congenital Bone Fractures 2
American Journal of Medical Genetics Part A · 2026
DOI: 10.1002/ajmg.a.64301 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2026. Verfasst von A Civit und 16 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Department, Tours University Hospital, Tours, France. Hauptthemen laut MEDLINE: Mutation, Missense, Muscular Atrophy, Spinal, Arthrogryposis, Fractures, Bone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Spinal muscular atrophy with congenital bone fractures 2 is a rare and severe autosomal recessive neuromuscular disorder caused by pathogenic variants in ASCC1 . This condition characterized by prenatal onset of severe hypotonia with fetal hypokinesia and congenital contractures results in arthrogryposis multiplex congenita, and increased incidence of prenatal fractures. To date, only truncating variants, loss of function and splicing variants have been described. Here, we report the first homozygous missense variant in ASCC1 identified prenatally in two full siblings with fetal akinesia deformation sequence. This variant affects a highly conserved residue within the RNA‐ligase‐like domain and leads to a nearly total absence of ASCC1 protein in muscle. This report broadens the knowledge on the pathogenesis of this disorder showing that missense variants should also be considered. It also highlights the importance of precise ultrasound examination combined with molecular genetic testing in the prenatal diagnosis of this severe neuromuscular disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics Department, Tours University Hospital, Tours, France.
- Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, Tours, France.
- Department of Anatomy and Pathological Cytology, Department of Genetics and Reference Center for Developmental Abnormalities, Univ Rouen Normandie, Normandie Univ, Inserm U1245 and CHU Rouen, Rouen, France.
- Univ Rouen Normandie, INSERM U1245, Team Epigenetics and Pathophysiology of Neurodevelopmental Disorders and Department of Pathology, Rouen University Hospital, Rouen, France.
- Department of Anatomy and Pathological Cytology, Tours University Hospital, University of Tours, France.
- Department of Gynecology, Bourges Hospital, Bourges, France.
ORCID-Profile: A Civit, M L Vuillaume
Zitieren
APA
Civit, A., Kerbellec, L., Laurenceau, D., Ung, D. C., Moizard, M. P., Ronce, N., Gueguen, P., Laumonnier, F., Bréhin, A. C., Marguet, F., Laquerrière, A., Bergemer Fouquet, A. M., Cirier, J., Blesson, S., Arpin, S., Jeanne, M., & Vuillaume, M. L. (2026). Variant Update on ASCC1 : Characterization of the First Homozygous Missense Variant Involved in Prenatal‐Onset Spinal Muscular Atrophy With Congenital Bone Fractures 2. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64301
Vancouver
Civit A, Kerbellec L, Laurenceau D, Ung DC, Moizard MP, Ronce N, et al. Variant Update on ASCC1 : Characterization of the First Homozygous Missense Variant Involved in Prenatal‐Onset Spinal Muscular Atrophy With Congenital Bone Fractures 2. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.64301
BibTeX
@article{Civit2026,
author = {Civit, A and Kerbellec, L and Laurenceau, D and Ung, D C and Moizard, M P and Ronce, N and Gueguen, P and Laumonnier, F and Bréhin, A C and Marguet, F and Laquerrière, A and Bergemer Fouquet, A M and Cirier, J and Blesson, S and Arpin, S and Jeanne, M and Vuillaume, M L},
title = {Variant Update on ASCC1 : Characterization of the First Homozygous Missense Variant Involved in Prenatal‐Onset Spinal Muscular Atrophy With Congenital Bone Fractures 2},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
doi = {10.1002/ajmg.a.64301}
}
EUVIMED